Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if IRON is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
48 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 29 days ago
Red flags: 1
217 filers reported a long position in IRON for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $358M | 4.9M | -12.4% |
| BlackRock, Inc. | $180.5M | 2.5M | +8.5% |
| RA CAPITAL MANAGEMENT, L.P. | $179.2M | 2.5M | Unchanged |
| JPMORGAN CHASE & CO | $139.9M | 1.9M | +36.8% |
| PRICE T ROWE ASSOCIATES INC /MD/ | $137.2M | 1.9M | +21% |
| WELLINGTON MANAGEMENT GROUP LLP | $127.4M | 1.7M | +0.3% |
| STATE STREET CORP | $120.6M | 1.6M | -2.9% |
| Vestal Point Capital, LP | $113.4M | 1.6M | +121.4% |
| Atlas Venture Life Science Advisors, LLC | $110.7M | 1.5M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $100.1M | 1.4M | -0.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.